Comprehensive Stock Comparison
Compare Diversified Healthcare Trust (DHC) vs Welltower Inc. (WELL) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | WELL | 38.0% revenue growth vs DHC's 2.8% |
| Quality / Margins | WELL | 8.6% net margin vs DHC's -18.6% |
| Stability / Safety | WELL | Beta 0.29 vs DHC's 0.75 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | DHC | +140.3% vs WELL's +36.8% |
| Efficiency (ROA) | WELL | 1.4% ROA vs DHC's -6.6%, ROIC 0.9% vs -0.9% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Diversified Healthcare Trust is a real estate investment trust that owns and operates healthcare-related properties including medical office buildings, senior living communities, and life science facilities. It generates revenue primarily through property rental income — with medical office properties contributing roughly 60% of net operating income and senior living communities about 40% — along with management fees from its operating partner. The company's competitive advantage lies in its specialized healthcare real estate portfolio and its long-term management relationship with The RMR Group, which provides operational expertise in the healthcare property sector.
Welltower is a healthcare-focused real estate investment trust that owns and invests in seniors housing communities, post-acute care facilities, and outpatient medical properties. It generates revenue primarily through rental income from its healthcare real estate portfolio — with seniors housing contributing roughly 60% of net operating income, outpatient medical properties about 25%, and post-acute care facilities the remainder. The company's competitive advantage lies in its scale and strategic partnerships with leading healthcare operators, creating a diversified portfolio concentrated in high-growth markets across the U.S., Canada, and the U.K.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
DHC leads in 3 of 6 categories (Valuation Metrics, Total Returns). WELL leads in 2 (Financial Metrics, Profitability & Efficiency). 1 tied.
Financial Metrics (TTM)
WELL is the larger business by revenue, generating $10.8B annually — 7.0x DHC's $1.5B. WELL is the more profitable business, keeping 8.6% of every revenue dollar as net income compared to DHC's -18.6%. On growth, WELL holds the edge at +46.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | DHCDiversified Healt… | WELLWelltower Inc. |
|---|---|---|
| RevenueTrailing 12 months | $1.5B | $10.8B |
| EBITDAEarnings before interest/tax | $292M | $2.6B |
| Net IncomeAfter-tax profit | -$286M | $934M |
| Free Cash FlowCash after capex | -$16M | $2.1B |
| Gross MarginGross profit ÷ Revenue | -16.0% | +20.9% |
| Operating MarginEBIT ÷ Revenue | +2.0% | +4.9% |
| Net MarginNet income ÷ Revenue | -18.6% | +8.6% |
| FCF MarginFCF ÷ Revenue | -1.0% | +19.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -0.0% | +46.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +75.5% | -26.3% |
Valuation Metrics
On an enterprise value basis, DHC's 6.9x EV/EBITDA is more attractive than WELL's 54.4x.
| Metric | DHCDiversified Healt… | WELLWelltower Inc. |
|---|---|---|
| Market CapShares × price | $1.6B | $144.3B |
| Enterprise ValueMkt cap + debt − cash | $1.5B | $142.0B |
| Trailing P/EPrice ÷ TTM EPS | -5.68x | 149.01x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 73.28x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 6.88x | 54.40x |
| Price / SalesMarket cap ÷ Revenue | 1.06x | 13.31x |
| Price / BookPrice ÷ Book value/share | 0.98x | 3.26x |
| Price / FCFMarket cap ÷ FCF | — | 50.06x |
Profitability & Efficiency
WELL delivers a 2.2% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-17 for DHC. On the Piotroski fundamental quality scale (0–9), WELL scores 5/9 vs DHC's 3/9, reflecting solid financial health.
| Metric | DHCDiversified Healt… | WELLWelltower Inc. |
|---|---|---|
| ROE (TTM)Return on equity | -17.2% | +2.2% |
| ROA (TTM)Return on assets | -6.6% | +1.4% |
| ROICReturn on invested capital | -0.9% | +0.9% |
| ROCEReturn on capital employed | -0.8% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 |
| Debt / EquityFinancial leverage | — | 0.07x |
| Net DebtTotal debt minus cash | -$105M | -$2.2B |
| Cash & Equiv.Liquid assets | $105M | $5.0B |
| Total DebtShort + long-term debt | $0 | $2.8B |
| Interest CoverageEBIT ÷ Interest expense | -0.19x | 0.81x |
Total Returns (with DRIP)
A $10,000 investment in WELL five years ago would be worth $32,119 today (with dividends reinvested), compared to $14,904 for DHC. Over the past 12 months, DHC leads with a +140.3% total return vs WELL's +36.8%. The 3-year compound annual growth rate (CAGR) favors DHC at 91.5% vs WELL's 42.6% — a key indicator of consistent wealth creation.
| Metric | DHCDiversified Healt… | WELLWelltower Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +35.9% | +11.2% |
| 1-Year ReturnPast 12 months | +140.3% | +36.8% |
| 3-Year ReturnCumulative with dividends | +602.0% | +190.2% |
| 5-Year ReturnCumulative with dividends | +49.0% | +221.2% |
| 10-Year ReturnCumulative with dividends | -21.4% | +270.5% |
| CAGR (3Y)Annualised 3-year return | +91.5% | +42.6% |
Risk & Volatility
WELL is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than DHC's 0.75 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | DHCDiversified Healt… | WELLWelltower Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.75x | 0.29x |
| 52-Week HighHighest price in past year | $6.85 | $215.56 |
| 52-Week LowLowest price in past year | $2.00 | $130.29 |
| % of 52W HighCurrent price vs 52-week peak | +98.7% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 68.1 | 69.0 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 2.5M |
Analyst Outlook
Wall Street rates DHC as "Hold" and WELL as "Buy". Consensus price targets imply 6.9% upside for WELL (target: $221) vs -26.0% for DHC (target: $5).
| Metric | DHCDiversified Healt… | WELLWelltower Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $5.00 | $221.45 |
| # AnalystsCovering analysts | 17 | 34 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | 3 | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Mar 20 | Feb 26 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | 100 | 86.39 | -13.6% |
| Welltower Inc. (WELL) | 100 | 249.04 | +149.0% |
Welltower Inc. (WELL) returned +221% over 5 years vs Diversified Healthc… (DHC)'s +49%. A $10,000 investment in WELL 5 years ago would be worth $32,119 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | $1.1B | $1.5B | +45.4% |
| Welltower Inc. (WELL) | $4.3B | $10.8B | +154.9% |
Diversified Healthcare Trust's revenue grew from $1.1B (2016) to $1.5B (2025) — a 4.2% CAGR. Welltower Inc.'s revenue grew from $4.3B (2016) to $10.8B (2025) — a 11.0% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | 13.4% | -18.6% | -239.2% |
| Welltower Inc. (WELL) | 25.4% | 8.6% | -65.9% |
Diversified Healthcare Trust's net margin went from 13% (2016) to -19% (2025). Welltower Inc.'s net margin went from 25% (2016) to 9% (2025).
Chart 4P/E Ratio History — 9 Years
| Stock | 2017 | 2025 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | 30.9 | 4.2 | -86.4% |
| Welltower Inc. (WELL) | 50.6 | 133.5 | +163.8% |
Diversified Healthcare Trust has traded in a 4x–31x P/E range over 3 years; current trailing P/E is ~-6x. Welltower Inc. has traded in a 27x–219x P/E range over 9 years; current trailing P/E is ~149x.
Chart 5EPS Growth — 10 Years
| Stock | 2016 | 2025 | Change |
|---|---|---|---|
| Diversified Healthc… (DHC) | 0.6 | -1.19 | -298.3% |
| Welltower Inc. (WELL) | 2.81 | 1.39 | -50.5% |
Diversified Healthcare Trust's EPS grew from $0.60 (2016) to $-1.19 (2025) — a NaN% CAGR. Welltower Inc.'s EPS grew from $2.81 (2016) to $1.39 (2025) — a -8% CAGR.
Chart 6Free Cash Flow — 5 Years
Diversified Healthcare Trust generated $-20M FCF in 2025 (+69% vs 2021). Welltower Inc. generated $3B FCF in 2025 (+129% vs 2021).
DHC vs WELL: Frequently Asked Questions
8 questions · data-driven answers · updated daily
01Is DHC or WELL a better buy right now?
Welltower Inc. (WELL) offers the better valuation at 149.0x trailing P/E (73.3x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — DHC or WELL?
Over the past 5 years, Welltower Inc. (WELL) delivered a total return of +221.2%, compared to +49.0% for Diversified Healthcare Trust (DHC). A $10,000 investment in WELL five years ago would be worth approximately $32K today (assuming dividends reinvested). Over 10 years, the gap is even starker: WELL returned +270.5% versus DHC's -21.4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — DHC or WELL?
By beta (market sensitivity over 5 years), Welltower Inc. (WELL) is the lower-risk stock at 0.29β versus Diversified Healthcare Trust's 0.75β — meaning DHC is approximately 161% more volatile than WELL relative to the S&P 500.
04Which has better profit margins — DHC or WELL?
Welltower Inc. (WELL) is the more profitable company, earning 8.6% net margin versus -18.6% for Diversified Healthcare Trust — meaning it keeps 8.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: WELL leads at 4.9% versus -2.6% for DHC. At the gross margin level — before operating expenses — WELL leads at 20.9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Is DHC or WELL more undervalued right now?
Analyst consensus price targets imply the most upside for WELL: 6.9% to $221.45.
06Which pays a better dividend — DHC or WELL?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is DHC or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc. (WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.29), +270.5% 10Y return). Both have compounded well over 10 years (WELL: +270.5%, DHC: -21.4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between DHC and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.